Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort stud...

by Guoli Du, Wanrun Xie, Yinxia Su, Yao Ma, Xiaoming Gao, Sheng Jiang, Huazheng Liang
Published 2020-10-01